Abstract Submission

Authors who submit an abstract of a paper confirm that they have not previously published these data, that they have not previously presented them at a large national annual scientific meeting, and that they are not planning to present or publish them prior to the dates of this AACR conference.

The Conference Co-Chairpersons will evaluate the scientific quality of the submitted abstracts on the basis of the following criteria: novelty of the research, significance of the findings, and clarity. Authors should be particularly cognizant of the importance of setting forth the objectives and hypotheses of the study in a clear, succinct manner and of summarizing the new, unpublished results. If an abstract is poorly written such that the committee cannot determine its novelty and importance, the paper will not be accepted for presentation at the conference.

Authors submitting abstracts for presentation at this AACR conference should consider the following:

  1. Abstracts must describe in a succinct manner the purposes and results of the research so that the quality, originality, and comprehensiveness of the work can be evaluated by the committee. Each abstract should contain: (a) an introductory sentence indicating the purposes of the study; (b) a brief description of pertinent experimental procedures; (c) a summary of the new, unpublished data; and (d) a statement of the conclusions. Authors must accept sole responsibility for the statements in their abstracts. All abstracts should be submitted in English and American spelling should be used throughout.
  2. Titles should be indicative of the content of the abstract. All words necessary to identify the subject matter should be included in the title to facilitate electronic retrieval (if applicable). Avoid nonstandard abbreviations in abstract titles.
  3. Abbreviations may be used in the body of an abstract if they are defined at their first mention in the text. Complex therapeutic regimens must be identified.
  4. The combined length of the abstract title and body should not exceed 4,000 characters (including spaces). The author and institution list is not included in the character limit. The online submitter will not accept abstracts that exceed this limit.
  5. PLEASE NOTE: The AACR is committed to the advancement of cancer research and the cure and prevention of cancer through the facilitation of communication and full dissemination of knowledge among scientists and others dedicated to the cancer problem. Therefore, the AACR requires strict compliance with the following regulation:
    • When biological or chemical data pertaining to chemical entities are an integral part of the research, the chemical structure, method of preparation, and patent or reference numbers must be presented. If for any reason this information cannot be provided when the paper is presented at the conference, the abstract on this work should not be submitted for consideration.
  6. Because of administrative and time constraints, supplemental data submitted along with the abstract cannot be transmitted to the committee for review.
  7. The accuracy of the submitted abstract is the responsibility of the authors. Every effort will be made to publish the abstract exactly as submitted. Authors should prepare and proofread their abstracts carefully prior to submission. Errors made on your submitted abstract are likely to appear in print.
  8. Authors are strongly encouraged to print a hard copy of their abstract for their records before submitting.
  9. All PRESENTERS must register to attend this AACR conference.
  10. If an abstract is accepted and the PRESENTER does not register, the abstract may be withdrawn.
  11. Abstract submitters will receive an initial notification of receipt in the form of a confirmation screen. Notifications of abstract receipt will be sent to the ABSTRACT SUBMITTER and PRESENTER.

  • Molecular and Cellular Biology
  • Tumor Biology
  • Carcinogenesis
  • Cancer Chemistry
  • Clinical Research (Not including clinical trials)
  • Clinical Trials
  • Endocrinology
  • Epidemiology
  • Experimental and Molecular Therapeutics
  • Immunology
  • Prevention Research

All presentations accepted will be poster. Only those abstracts that have been reviewed and selected by the review committee may be presented. All individuals listed as ABSTRACT PRESENTERS will be notified of acceptance or rejection by email approximately three weeks after the abstract submission deadline. Notices and instructions will be sent to the PRESENTER’S email address provided at the time of abstract submission. If an abstract is not selected for presentation, the presenter may request a full refund of the registration fee by contacting registration@aacr.com.cn.

 

Abstracts selected for presentation during the conference will be printed in the Conference Proceedings from submitted material. Every effort will be made to reproduce the content of the abstracts as submitted, except in certain circumstances where changes may be made to comply with AACR style. Abstract titles and authors will be posted on the AACR website before the conference begins (only titles and authors, no data will be posted online before or after the conference). Poster boards will be 90cm width x 250cm height (a poster in A0 size 84cm x 119cm will be a useful size) and AACR will provide poster nu mbers and pushpins. 

After the submission deadline, abstracts may be withdrawn only by written request from the ABSTRACT PRESENTER. The request may be sent by email to registration@aacr.com.cn and must be received at least 30 days prior to the start of the conference.

 

Abstract Submission Deadline: 31 July.